Publications by authors named "Eschwege F"

The French society of oncological radiotherapy (Société française de radiothérapie oncologique, SFRO) was created in 1990. On the occasion of its thirtieth annual congress, in October 2019, a session was devoted to it, with the objective of exposing its functioning, its actions and its productions during these three decades during which radiotherapy and oncology have undergone unprecedented transformations. We propose in this article to outline the content of this session.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the link between post-radiation therapy overreactions (OR) in patients and their clinical radiosensitivity, highlighting the lack of consensus on effective prediction methods since 2003.
  • Researchers collected skin biopsy samples from patients with varying degrees of OR, focusing on skin fibroblasts from different sensitivity groups and analyzing their DNA damage response after radiation.
  • Findings suggest that OR patients experience a delay in the ATM protein's activity rather than a complete repair defect, leading to a proposed classification of human radiosensitivity into three groups based on their reaction severity.
View Article and Find Full Text PDF

Hypofractionation is not a new idea in radiotherapy. The use of a few high-dose fractions has been proposed by some pioneers of our specialty in the early years of the 20th century. Hypofractionation then reappeared several times in the next decades, based on successive radiobiological concepts, a number of them having been shown to be wrong.

View Article and Find Full Text PDF

Many clinical studies have showed the key role of radiotherapy in anticancer treatment strategy. Radiations are delivered alone or in combination with systemic therapies. In recent years, the main goal of all clinical developments has focused on improving clinical benefit, with an increased tumour control and a higher normal tissue protection.

View Article and Find Full Text PDF

Background: The aim was to identify predictors of outcome in patients with localized prostate cancer treated with external beam radiotherapy (EBRT), with or without androgen deprivation therapy (ADT).

Materials And Methods: A total of 448 patients with prostate cancer received EBRT alone (n = 361, group 1) or ADT followed by EBRT (n = 87, group 2). In group 2, ADT was initiated 3 months before EBRT.

View Article and Find Full Text PDF

For the second year, the French Radiotherapy Database presents information from French radiation oncology centers. Among 179 centers, 159 have participated (90 %). The number of accelerators increased from 371 to 384 between 2006 and 2007, 11 % of these machines are more than 15 years old.

View Article and Find Full Text PDF
Article Synopsis
  • This cohort study explored the link between childhood radiation treatment for skin hemangiomas and the development of thyroid cancer and adenomas in later life.
  • Among the 4,767 patients analyzed, 11 developed thyroid carcinoma and 44 developed adenomas over an average follow-up of 35 years, with a significant correlation between radiation dose to the thyroid and cancer risk.
  • The findings suggest that past radiation exposure increases the likelihood of thyroid issues, highlighting the need for careful monitoring of patients who received such treatments.
View Article and Find Full Text PDF

Accidents which recently occured in external radiotherapy led the French Ministry of Health to implement a programme aimed at increasing quality and safety of treatments. We report the actions of the French society of radiation oncology in the field of this programme called Feuille de route.

View Article and Find Full Text PDF
Article Synopsis
  • The radiation oncology accident at the Public General Hospital in Epinal is the most severe in France, classified as level 6 on a scale of 10 due to treatment process errors and misuse of dynamic wedges, leading to a 20% overdose in certain patients.
  • Between May 2005 and August 2006, prostate cancer patients suffered serious clinical consequences, with adverse effects rated from grade 2 to 5 on the CTCAE scale.
  • In response to the incident, treatments were halted for several months to revamp department management focusing on quality and safety, while emphasizing the need for robust quality control measures in the future.
View Article and Find Full Text PDF

Within the frame of Plan cancer and events of radioprotection which occurred since 2005, the community of radiation oncologists is aware under the umbrella of SFRO of the technologic, structural and cultural mutation that our discipline is going through, with the support of the tutelages. We report on the actions the SFRO has participated with, or initiated these last 2 years.

View Article and Find Full Text PDF

Background: Although ionizing radiation has been proposed for the prevention of intimal hyperplasia in coronary and peripheral arteries in multicenter clinical trials, information is lacking on how irradiation affects arterial histology after stenting and especially how it affects the edges of the stent. We investigated intimal hyperplasia recasting with histological changes in arterial wall at the edges of the stent after arterial stenting followed by adequate external radiation for the prevention of intimal hyperplasia in pigs.

Materials And Methods: The aorta was experimentally stented in 30 pigs who were then assigned to two groups: irradiation with 20 Gy and a control group with no irradiation.

View Article and Find Full Text PDF

Purpose: To evaluate chronic xerostomia and tumor control 18 and 24 months after initial treatment with amifostine in a randomized controlled trial of patients with head-and-neck cancer; at 12 months after radiotherapy (RT), amifostine had been shown to reduce xerostomia without changing tumor control.

Methods And Materials: Adults with head-and-neck cancer who underwent once-daily RT for 5-7 weeks (total dose, 50-70 Gy) received either open-label amifostine (200 mg/m2 i.v.

View Article and Find Full Text PDF

Background: Although ionizing radiation has been proposed for the prevention of intimal hyperplasia in coronary and peripheral arteries, information is lacking on how irradiation affects arterial histology and neointimal smooth-muscle cell proliferation-the hallmark of restenosis. We chronologically investigated early histological changes and quantitative changes in arterial wall cell proliferation after arterial injury followed by external radiation for the prevention of intimal hyperplasia in rabbits.

Materials And Methods: The aorta was experimentally injured in 26 rabbits who were then assigned to two groups: irradiation with 20 Gy and a control group with no irradiation.

View Article and Find Full Text PDF
Article Synopsis
  • A study looked at the long-term effects of radiation treatment on young patients who had a skin condition called hemangioma between 1940 and 1973.
  • Out of over 7,000 patients, many were treated with radiotherapy and some died of cancer later on, especially those who received a specific type of radiation called (226)Ra.
  • The results suggest that kids treated with this radiation may have a higher chance of dying from cancer, so it's important to keep an eye on these patients in the future.
View Article and Find Full Text PDF

Background: Recent reports describe spontaneous dissections and aneurysms after coronary and peripheral artery irradiation for the prevention of intimal hyperplasia. We investigated histological changes and the vasomotor reaction in the vascular wall after external radiation for the prevention of intimal hyperplasia in rabbits.

Materials And Methods: The aorta was experimentally injured in 34 rabbits who were then assigned to one of three groups: irradiation with 20 Gy; with 25 Gy; and a control group with no irradiation.

View Article and Find Full Text PDF

In recent years there has been intensive research on the use of ionizing radiation for inhibition of intimal hyperplasia (IH). Results have clearly established that beta ionizing radiation delivered from an endoluminal source after angioplasty inhibits intimal restenosis. This effect has been confirmed by recent multicenter clinical trials in patients undergoing coronary dilatation.

View Article and Find Full Text PDF